1 Min Read
Dec 16 (Reuters) - UK's Competition and Markets Authority
* Has provisionally found that Actavis UK has broken competition law by charging excessive prices to NHS for hydrocortisone tablets.
* Actavis UK raised price of 10mg hydrocortisone tablets by over 12,000 pct compared to branded version of drug sold by a different co prior to April 2008
* Company also increased price of 20mg hydrocortisone tablets by nearly 9,500 pct compared to previous branded price Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)